Cannabis compounds are being used to tackle kidney failure amongst diabetics in a major new research project. Researchers working on the Aberdeen University study, which is funded by Diabetes UK, will explore whether synthetic cannabinoid compounds can be used to make the kidneys respond better to insulin.
While a Silicon Valley company can legally protect its most valuable technology with federal patents, cannabis companies cannot secure their core products as long as the federal government continues to classify marijuana as an illegal drug on par with heroin — one with “no accepted medical use.”